Since stability is a great concern in the industry because pharmaceuticals must be safe and effective, on April 27th we will be having a live session on Stability issues related to softgels, presented by two of our R&D experts, Diego Monterroza and Claudia Silva. In this topic we will reinforce the QbD methodology in order to comprehend the effect of diverse formulation variables on the stability and minimize the risk of failure at stability conditions. In addition, we will talk about the main physical and chemical issues in SGC´s, key factors involved and the proposed tests, case studies to illustrate how to evaluate the stability at the pre formulation phase, important variables in particular cases, the risk analysis, experimental design, and the respective conclusions and results.
We invite you to join us in this webinar and to be part in this task of making softgel product development a part of the QbD approach.
When: April 27
Time: 3PM London / 10AM New York